Infection Control News

Routine HPV vaccination rates could be improved if children were vaccinated earlier, according to a new study.

SEATTLE — Two studies presented at the Conference on Retroviruses and Opportunistic infections demonstrated high adherence levels and acceptability of long-acting, injectable PrEP for HIV prevention among varying groups of people.

After many infectious disease fellowship programs went unfilled on the latest Match Day, physicians in the field shared why they think the area has recently become more undesirable than in previous years.

Urban families, Black and multiracial children and families with low socioeconomic status faced the highest rates of pediatric care disruption during the COVID-19 pandemic, a study found.

Preliminary estimates published Thursday in MMWR and presented this week by the CDC indicate that this season’s influenza vaccine offered significant protection among all ages.

SEATTLE — Long-acting cabotegravir plus rilpivirine administered every 2 months was noninferior to daily oral HIV medication and was preferred by most participants in a phase 3b randomized trial, according to data presented here.

SEATTLE — In this video, Jeanne M. Marrazzo, MD, MPH, director of the division of infectious diseases at the University of Alabama at Birmingham School of Medicine, talks about PrEP adherence and efficacy in cisgender women.

SEATTLE — Study findings presented Wednesday at the Conference on Retroviruses and Opportunistic Infections provided more evidence of the effectiveness of vaccines against mpox.

A study that used wastewater signals to identify cases of COVID-19 found that even a small increase in the proportion of people wearing masks at elementary schools in one California county significantly reduced the chance of a case.

A recent review of randomized controlled trials — most of which were conducted before the COVID-19 pandemic — has become part of the debate on the effectiveness of masks in preventing the spread of respiratory illnesses.